Fengju Chen
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 15
- Developmental Neuroscience top 5%
- Neurology top 5%
- Genetics top 5%
- Glioma Diagnosis and Treatment 4
- Oncology top 5%
- Cancer Cells and Metastasis 5
-
- Epigenetics and DNA Methylation 13
- RNA modifications and cancer 4
- Cancer-related gene regulation 4
- Histone Deacetylase Inhibitors Research 3
-
- Ferroptosis and cancer prognosis 6
- Co-authors
- Chad J. CreightonSooryanarayana VaramballyDarshan S. ChandrashekarQianxing MoKeith Syson ChanJing XiaoAntonina V. KurtovaPhilip Levy Ho
- Partner nations
- United StatesChinaCanada
In The Last Decade
Fengju Chen
61 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Cancer Research 703
- Developmental Neuroscience 147
- Neurology 268
- Genetics 278
- Oncology 680
Countries citing papers authored by Fengju Chen
This map shows the geographic impact of Fengju Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengju Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengju Chen more than expected).
Fields of papers citing papers by Fengju Chen
This network shows the impact of papers produced by Fengju Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengju Chen. The network helps show where Fengju Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fengju Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 11 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 19 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 14 | |
| 8 | 2022 | 115 | |
| 9 | 2021 | 29 | |
| 10 | 2021 | 31 | |
| 11 | 2021 | 59 | |
| 12 | 2021 | 11 | |
| 13 | 2021 | 13 | |
| 14 | 2021 | 7 | |
| 15 | 2020 | 19 | |
| 16 | 2019 | 16 | |
| 17 | 2019 | 73 | |
| 18 | 2018 | 27 | |
| 19 | 2018 | 61 | |
| 20 | 2015 | 118 |
About Fengju Chen
Fengju Chen is a scholar working on Cancer Research, Genetics, Hematology, Molecular Biology and Oncology, having authored 62 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (15 papers), Epigenetics and DNA Methylation (13 papers), Ferroptosis and cancer prognosis (6 papers), Cancer Cells and Metastasis (5 papers), Glioma Diagnosis and Treatment (4 papers), RNA modifications and cancer (4 papers), Cancer-related gene regulation (4 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Cancer Research (703 citations), Developmental Neuroscience (147 citations), Neurology (268 citations), Genetics (278 citations) and Oncology (680 citations). Fengju Chen has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Chad J. Creighton, Sooryanarayana Varambally, Darshan S. Chandrashekar, Qianxing Mo, Keith Syson Chan, Jing Xiao, Antonina V. Kurtova, Philip Levy Ho, Seth P. Lerner and Ross Krasnow. Their work appears in journals such as Nature Communications, Scientific Reports, Oncotarget, Neoplasia and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.